Dr. Alexandra Labiak, MD

NPI: 1386105880
Total Payments
$2,288
2024 Payments
$205.90
Companies
4
Transactions
10

Payment Breakdown by Category

Consulting$1,512 (66.1%)
Food & Beverage$776.18 (33.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $1,512 1 66.1%
Food and Beverage $776.18 9 33.9%

Top Paying Companies

Company Total Records Latest Year
GENZYME CORPORATION $1,631 2 $0 (2023)
Incyte Corporation $412.42 5 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $163.87 2 $0 (2023)
ABBVIE INC. $81.15 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $205.90 2 Incyte Corporation ($124.75)
2023 $2,082 8 GENZYME CORPORATION ($1,631)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/03/2024 ABBVIE INC. Food and Beverage In-kind items and services $81.15 General
06/13/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $124.75 General
Category: Dermatology
10/24/2023 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $134.99 General
Category: Dermatology
04/22/2023 Boehringer Ingelheim Pharmaceuticals, Inc. Food and Beverage In-kind items and services $125.00 General
04/21/2023 GENZYME CORPORATION DUPIXENT (Biological) Consulting Fee Cash or cash equivalent $1,512.00 General
Category: Immunology
04/21/2023 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $118.74 General
Category: Immunology
04/21/2023 Boehringer Ingelheim Pharmaceuticals, Inc. SPEVIGO (Drug) Food and Beverage In-kind items and services $38.87 General
Category: IMMUNOLOGY
03/09/2023 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $127.91 General
Category: Dermatology
02/23/2023 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $20.34 General
Category: Dermatology
02/23/2023 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $4.43 General
Category: Dermatology

About Dr. Alexandra Labiak, MD

Dr. Alexandra Labiak, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2019. The National Provider Identifier (NPI) number assigned to this provider is 1386105880.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexandra Labiak, MD has received a total of $2,288 in payments from pharmaceutical and medical device companies, with $205.90 received in 2024. These payments were reported across 10 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($1,512).

Practice Information

Products in Payments

  • DUPIXENT (Biological) $1,631
  • OPZELURA (Drug) $412.42
  • SPEVIGO (Drug) $38.87

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Bronx